戻る Agenda
Session 2 : Operation Issues, Protocol Issues
Session Chair(s)
Morihiko Hayashi, DVM
Clinical Development, Clinical Science & Strategy, Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Hitomi Okuma, MD, PhD
Head, International Research and Development Section, National Cancer Center Hospital, Japan
Rare Cancer Treatment Development Platform : MASTER KEY Project
Misato Doniwa
Clinical Project Manager, Clinical Operation, IQVIA Services Japan K.K., Japan
Considerations and Barriers for Clinical Operations in the Basket Study of Entrectinib